Akpentolate
Akpentolate Brand names, Akpentolate Analogs
Akpentolate Brand Names Mixture
- No information avaliable
Akpentolate Chemical_Formula
C17H25NO3
Akpentolate RX_link
No information avaliable
Akpentolate fda sheet
Akpentolate msds (material safety sheet)
Akpentolate Synthesis Reference
No information avaliable
Akpentolate Molecular Weight
291.385 g/mol
Akpentolate Melting Point
139 oC (hydrochloride salt)
Akpentolate H2O Solubility
No information avaliable
Akpentolate State
Solid
Akpentolate LogP
3.124
Akpentolate Dosage Forms
Ophthalmic solution (eye drops)
Akpentolate Indication
Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.
Akpentolate Pharmacology
Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.
Akpentolate Absorption
Absorbed following ophthalmic administration.
Akpentolate side effects and Toxicity
Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.
Akpentolate Patient Information
No information avaliable
Akpentolate Organisms Affected
Humans and other mammals
